|
|
 |
|
MRK: Merck & Co - Stock News |
Enter Ticker:
|
|
| Nov 21, 2009 |
Applied Materials, Merck and Braunschweig University Report Receiving Funding by German Government for OLED Research |
| Nov 21, 2009 |
Aegis Rolls out Latest Version of Discoverant |
| Nov 21, 2009 |
River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries |
| Nov 20, 2009 |
Merck Presents Phase IIb Study Results at AHA Annual Scientific Sessions |
| Nov 20, 2009 |
PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, November 20, 2009: KIRK, PPD, MRK, BAM, EEE and S |
| Nov 20, 2009 |
Sector Update: Health Care Shares Lower in Pre-Market Session - Merck Approved for Elonva by CHMP in EU |
| Nov 20, 2009 |
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) |
| Nov 19, 2009 |
Critical Alerts For Merck, Monsanto, Urban Outfitters, Petrohawk Energy, and Vistaprint Released By Seven Summits Research |
| Nov 19, 2009 |
LGND: Receives $2M Milestone Payment from Merck's N. V. Organon |
| Nov 19, 2009 |
Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc. |
| Nov 19, 2009 |
UTA Baseball Inks Eight in Early Signing Period |
| Nov 18, 2009 |
Dispensary of Hope Partners with Leading Pharma Companies to Expand Prescription Medications Access to Tennesseans in Need |
| Nov 18, 2009 |
Merck's new CP wins S&P's top-notch short-term rating |
| Nov 17, 2009 |
Elevated cholesterol problems for Merck |
| Nov 17, 2009 |
Merck's Investigational Anacetrapib Phase IIb Study Results Presented at American Heart Association Annual Scientific Sessions |
| |
| ZACKS COMMENTARY FOR MRK |
| Nov 16, 2009 | Zacks Blog: Setback for Merck | | Nov 11, 2009 | Zacks Blog: Cornerstone Tops Zacks Ests | | Nov 11, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Enzon, Merck, OSI Pharmaceuticals, Pfizer and Bank of America Corporation | | Nov 10, 2009 | Zacks Blog: Enzon Beats, Announces Sell-off | | Nov 10, 2009 | Zacks Analyst Interviews: Big Pharma & Biotech | | Nov 10, 2009 | Industry Outlook: Big Pharma & Biotech | | Nov 09, 2009 | Zacks Blog: Big Pharma and Biotech | | Nov 09, 2009 | Zacks Blog: Santarus Reports Strong Quarter | | Oct 30, 2009 | Zacks Blog: Approval for Merck-SGP Merger | | Oct 28, 2009 | Zacks Blog: ev3 Beats Zacks Estimate | | Oct 27, 2009 | Zacks Blog: Vertex Posts Wider Loss | | Oct 26, 2009 | Zacks Blog: ACIP Recommends Glaxo's Cervarix |
|
|
Sponsored Links 
1.13